News | December 07, 2022
Global procalcitonin tests market set to surpass $2 billion in 2030: GlobalData
The use of procalcitonin testing for sepsis management is highest in the US
The use of procalcitonin testing for sepsis management is highest in the US
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
This product is based on Osmotic Controlled Release Oral Delivery System technology
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
The joint venture will help both the parties to further develop the high-margin service business
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Subscribe To Our Newsletter & Stay Updated
